ASTMH 2018

67th Annual Meeting

28 October – 1 November 2018
New Orleans, USA

  • Nathalie Strub-Wourgaft, NTD Director – presentation on fexinidazole in a symposium on sleeping sickness elimination
  • Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme – symposium on screening and diagnosis of Chagas disease
  • Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma

COR-NTD Annual Meeting

26-27 October 2018
New Orleans, USA

  • Sergio Sosa-Estani, Head of Chagas Clinical Program, and Andrea Marchiol, Chagas Access Project Manager – session on control and care of Chagas disease in health networks
  • Suman Rijal, Head Regional Office, DNDi India – presentation on VL/HIV co-infections and PKDL

Keystone Conference 2018

21st Century Drug Discovery and Development for Global Health

17-20 October 2018
Berlin, Germany

  • Nathalie Strub-Wourgaft, NTD Director – presentation on the new therapies for sleeping sickness
  • Charles Mowbray, Discovery Director – presentation on new orally active treatments for leishmaniasis

11th DNDi Partners’ Meeting: From innovation to access in Africa – the way forward

4 October 2018
Kampala, Uganda

  • DNDi’s biannual partners’ meeting will bring together some 250-300 health leaders, policy-makers, researchers, civil society groups, product developers, and donors.
  • Meeting sessions will highlight the significant changes made and those still needed in the landscape of research and development, capacity building and strengthening, and access to medicines for neglected diseases and patients on the African continent.

Paediatric HIV Stakeholders’ Meeting

3-4 October 2018
Kampala, Uganda

  • François Bompart, Director of Paediatric HIV/HCV Programmes, Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes, Jean-René Kiechel,Expert in R&D – panel discussion on DNDi‘s journey so far working on Paediatric HIV
  • Olawale Salami, Paediatric HIV Clinical Project Manager – panel discussion on access to child-adapted ARV formulations

Onchocerciasis Network Meeting

3-4 October 2018
Kampala, Uganda

  • Sabine Specth, Head of Filariasis Clinical Programme – presentation of unmet medical need of onchocerciasis patients and Target Product Profile
  • Belén Pedrique, Medical Manager – presentation on access strategies for new treatments for onchocerciasis
  • Florent Mbo, HAT Platform Coordinator – presentation of the HAT Platform

25th LEAP Platform Meeting

3-4 October 2018
Kampala, Uganda

  • DNDi – sessions on the LEAP Platform activities, policy, the AfriKADIA project, PKDL, and capacity strengthening

National Regulatory Conference (NRC) 2018

2-4 October 2018
Selangor, Malaysia

  • Marion Laumonier, Head of Regulatory Affairs – presentation on registration pathways and forum discussion on collaborative efforts between regulators and stakeholders

Seminar on Evidence in Action

1 October 2018 
Subang Jaya, Malaysia
Jean-Michel Piedagnel, Head of DNDi South East Asia – presentation on affordable treatment for hepatitis C

Ninth EDCTP Forum

17-21 September 2018 
Lisbon, Portugal
DNDi – symposia on synergies between diagnostics and treatment studies for HAT and on data-sharing

MedTrop 2018

Congress of the Brazilian Society of Tropical Medicine

2-5 September 2018 
Recife, Brazil
Posters on advances and challenges for Chagas disease and an access project in Colombia
DNDi participating in several round tables on Chagas disease and cutaneous leishmaniasis and the satellite forum FSBEIN